প্রচ্ছদ

Biomarkers of Neurodegenerative Disorders Current Progress and Future Directions /

This book presents state-of-the-art knowledge regarding fluid and imaging biomarkers of neurodegenerative disorders, including Alzheimer disease and related dementias (ADRD). A cadre of the top experts in the field discuss the diagnostic and prognostic value of established and emerging biomarkers in...

সম্পূর্ণ বিবরণ

সংরক্ষণ করুন:
গ্রন্থ-পঞ্জীর বিবরন
সংস্থা লেখক: SpringerLink (Online service)
অন্যান্য লেখক: Tarawneh, Rawan (Editor)
বিন্যাস: বৈদ্যুতিক বৈদ্যুতিন গ্রন্থ
ভাষা:ইংরেজি
প্রকাশিত: Cham : Springer Nature Switzerland : Imprint: Springer, 2025.
সংস্করন:1st ed. 2025.
বিষয়গুলি:
Neurosciences.
Diagnosis.
Neurology .
Neuropharmacology.
Neuroscience.
Neurology.
অনলাইন ব্যবহার করুন:https://doi.org/10.1007/978-3-031-80849-4
ট্যাগগুলো: ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
সূচিপত্রের সারণি:
  • Section 1: Fluid and Imaging Markers of Pathologies associated with Alzheimer Disease or other Related Dementias
  • Chapter 1: Fluid and Imaging Markers of Amyloid Pathology
  • Chapter 2: Fluid Markers of Tau Pathology
  • Chapter 3: Fluid and Imaging Markers of Synuclein Pathology
  • Chapter 4: Fluid and Imaging Markers of Synaptic Injury
  • Chapter 5: Fluid Markers of Neuronal and Axonal Injury
  • Chapter 6: Fluid and Imaging Markers of Glial Reactivity
  • Chapter 7: Fluid and Imaging Markers of Vascular Disease
  • Section 2: Fluid and Imaging Markers of Neurodegenerative Disorders
  • Chapter 8: Fluid and Imaging Markers of Alzheimer Disease
  • Chapter 9: Fluid and Imaging Markers of Frontotemporal Lobar Degeneration
  • Chapter 10: Fluid and Imaging Markers of Lewy body dementias
  • Chapter 11: Fluid and Imaging Markers of Huntington’s Disease
  • Section 3: Single and Integrated Omics Studies in Biomarker Discovery
  • Chapter 12: Proteomics for Novel Biomarker and Drug Target Discovery in Alzheimer Disease
  • Chapter 13: Genomics and Transcriptomics of Alzheimer Disease
  • Section 4: Biomarkers in Clinical and Translational Alzheimer Disease Research
  • Chapter 14: Biomarkers in Clinical Trials of Alzheimer Disease: An Overview
  • Chapter 15: Biomarkers As Outcome Measures in Clinical Trials of Alzheimer Disease
  • Chapter 16: Impact of Pre-analytical Factors on Fluid Biomarker Measurements in Alzheimer Disease
  • Chapter 17: Mild Behavioral Impairment and Alzheimer’s Disease Biomarker Sample Enrichment for Clinical Trial Screening and Recruitment
  • Section 5: Future Directions in Biomarker Research
  • Chapter 18: Extracellular Vesicles as Biomarkers in Alzheimer Disease and Related Dementias
  • Chapter 19: Sex Differences in Alzheimer Disease-Related Biomarkers and Dementia Risk
  • Chapter 20: Imaging Markers of Amyloid and Tau
  • Chapter 21: Novel Markers of Brain Endothelial Injury
  • Epilogue: Expert Commentary on Future Directions or Epilogue: Sex/racial differences, standardization, and TDP-43.

অনুরূপ উপাদানগুলি